SCHEMBL797362

SCHEMBL797362

CC(=O)CCN(C)Cc1ccc(C(C)(C)C)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 2/20 0.51
▸ TMEM97 Q5BJF2 1/20 0.51
▸ LMNA P02545 3/20 0.48
▸ KCNH2 Q12809 2/20 0.44
▸ NR1I2 O75469 1/20 0.44
▸ ADRA2A P08913 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ ACHE P22303 1/20 0.44
▸ SLC6A2 P23975 1/20 0.44
▸ HTR2A P28223 1/20 0.44
▸ SLC6A4 P31645 1/20 0.44
▸ ESRRG P62508 1/20 0.43
▸ ACKR3 P25106 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ NR1H4 Q96RI1 4/20 0.41
▸ EPHX2 P34913 2/20 0.41
▸ HIF1A Q16665 2/20 0.41
▸ PYCR1 P32322 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15942946 0.87 SIGMAR1 (0.58) SIGMAR1TMEM97LMNAKCNH2NR1I2
SCHEMBL798028 0.83 SIGMAR1 (0.47) SIGMAR1TMEM97LMNAKCNH2NR1I2
SCHEMBL5479984 0.80 CARM1 (0.56) SIGMAR1TMEM97RAB9AKMT2A
SCHEMBL15942948 0.77 SIGMAR1 (0.50) SIGMAR1TMEM97LMNAKCNH2NR1I2
SCHEMBL28049309 0.76 LMNA (0.49) SIGMAR1TMEM97LMNAKCNH2NR1I2
SCHEMBL18714783 0.76 HIF1A (0.53) SIGMAR1TMEM97LMNAKCNH2NR1I2
SCHEMBL2953957 0.75 ALDH1A1 (0.59) LMNAKCNH2ESRRGRAB9ANR1H4
SCHEMBL18714847 0.75 HIF1A (0.52) SIGMAR1TMEM97LMNAKCNH2NR1I2
SCHEMBL10223590 0.75 KCNH2 (0.64) SIGMAR1TMEM97LMNAKCNH2NR1I2
SCHEMBL5166698 0.74 SIGMAR1 (0.51) SIGMAR1TMEM97LMNAKCNH2NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8802663-B2 Pyrazole oxadiazole derivatives as S1P1 agonists MERCK SERONO SA (CH) 2014-08-12 — — US disclosed
US-20120071460-A1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS MERCK SERONO SA (CH) 2012-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071460-A1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS S1PR1, S1PR3, S1PR2 SIGMAR1 501/4885TMEM97 313/4885LMNA 4315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback